Belgium - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes
Since 2014, Belgium Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes was up 4.4% year on year. In 2019, the country was number 5 among other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes at €429.86 Per Capita. Belgium is overtaken by Ireland, which was number 4 with €447.21 Per Capita and is followed by France at €419.57 Per Capita. Switzerland topped the ranking with €666.37 Per Capita in 2019, a growth of 3.2% versus 2018. Latvia recorded the best 5 years average growth at +8.8% per year, while Romania witnessed the worst performance at -1.7% per year.
Loading...
Date | Euros Per Capita |
---|---|
2019 | 429.86 |
2018 | 427.66 |
2017 | 401.47 |
2016 | 383.92 |
2015 | 374.12 |
How does Belgium rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes?
# | 33 Countries | Euros Per Capita | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Switzerland
|
666.37 | 2019 | +3.1 % | +5.3 % | View data | |
2 |
#2
Germany
|
553.39 | 2019 | +2.3 % | +3.0 % | View data | |
4 |
#4
Ireland
|
447.21 | 2019 | -0.8 % | +2.1 % | View data | |
5 |
#5
Belgium
|
429.86 | 2019 | +0.5 % | +4.4 % | View data | |
6 |
#6
France
|
419.57 | 2019 | +0.6 % | +1.9 % | View data |